Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin

BACKGROUND: Gallbladder cancer (GBC) is likely to be diagnosed at progressive stages and shows a very poor prognosis. Combination therapy with gemcitabine and cisplatin (GEMCIS) has been widely used as first-line palliative chemotherapy for advanced GBC. This study was designed to investigate the ef...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMC Cancer
Главные авторы: You, Min su, Ryu, Ji Kon, Choi, Young Hoon, Choi, Jin Ho, Huh, Gunn, Paik, Woo Hyun, Lee, Sang Hyub, Kim, Yong-Tae
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2019
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6321682/
https://ncbi.nlm.nih.gov/pubmed/30611225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-5211-y
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы